The pledge builds on the collaboration between Oxford University , AstraZeneca and SII, the world’s largest maker of vaccines Vaccine maker Serum Institute of India (SII) has pledged 50 million pounds ($66.2 million) to the University of Oxford for setting up a research campus that would also house the institute behind the AstraZeneca -Oxford COVID-19 shot. The investment was made through the Indian company’s Serum Life Sciences unit, Oxford University said on Wednesday. The research building would be named after Serum’s billionaire owners, the Poonawalla family. The pledge builds on the collaboration between Oxford University, AstraZeneca and SII, the world’s largest maker of vaccines and the producer of a version of the British duo’s COVID-19 shot for low- and middle-income countries. SII has also agreed with the Jenner Institute, which was behind the Oxford-AstraZeneca COVID-19 vaccine, to produce and develop Jenner’s R21/Matrix-M malaria shot on a large scale. Th...